KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Net Income - Minority (2016 - 2020)

Aurinia Pharmaceuticals filings provide 4 years of Net Income - Minority readings, the most recent being -$398.8 million for Q3 2020.

  • On a quarterly basis, Net Income - Minority fell 222.32% to -$398.8 million in Q3 2020 year-over-year; TTM through Sep 2020 was -$398.8 million, a 222.32% decrease, with the full-year FY2019 number at -$273.5 million, down 142.96% from a year prior.
  • Net Income - Minority hit -$398.8 million in Q3 2020 for Aurinia Pharmaceuticals, down from -$239.0 million in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of -$112.6 million in Q4 2018 to a low of -$398.8 million in Q3 2020.
  • Median Net Income - Minority over the past 4 years was -$161.7 million (2017), compared with a mean of -$193.2 million.
  • Biggest five-year swings in Net Income - Minority: soared 32.08% in 2018 and later crashed 222.32% in 2020.
  • Aurinia Pharmaceuticals' Net Income - Minority stood at -$165.7 million in 2017, then skyrocketed by 32.08% to -$112.6 million in 2018, then plummeted by 142.96% to -$273.5 million in 2019, then tumbled by 45.82% to -$398.8 million in 2020.
  • The last three reported values for Net Income - Minority were -$398.8 million (Q3 2020), -$239.0 million (Q2 2020), and -$263.4 million (Q1 2020) per Business Quant data.